Reata Pharmaceuticals Inc Asset Turnover Ratio (RETA), as of second quarter 2023, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Reata Pharmaceuticals Inc   (NASDAQ: RETA)
 

Reata Pharmaceuticals Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Reata Pharmaceuticals Inc asset turnover ratio, the ability of Reata Pharmaceuticals Inc 's assets to generate revenue in the second quarter 2023, increased sequentially to 0.05 in the second quarter (Jun 30 2023), RETA's balance sheet remain strong.

Within sector Reata Pharmaceuticals Inc achieved the highest asset turnover ratio. While asset turnover ranking remained unchanged in the Second Quarter 2023 compared to previous quarter at no. .

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

RETA Asset Turnover Ratio (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter
Y / Y Asset Change -32.68 % -48.43 % -32.8 % -20.25 % -18.78 %
Y / Y Revenue Change 2885.04 % -78.67 % - -92.69 % -65.69 %
Asset Turnover Ratio (TTM) 0.05 0 - 0.01 0.02
RETA's Total Ranking # # # # #
Seq. Asset Change 21.26 % -14.48 % -29.76 % -7.59 % -7.11 %
Seq. Revenue Change 11564.62 % - - -29.13 % -16.63 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #

Asset Turnover Ratio Statistics
High Average Low
0 0 0
 




RETA Company Profile • Back to RETA Efficiency Comparisons • Compare RETA Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Jun 30 2023, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jun 30 2023 Assets at quarter ending Jun 30 2023
Zevra Therapeutics Inc   0.15 $ 16.542  Millions$ 111.798  Millions
Veru Inc   0.15 $ 14.913  Millions$ 101.182  Millions
Maxcyte inc   0.14 $ 40.685  Millions$ 281.453  Millions
Neuroone Medical Technologies Corp  0.14 $ 1.279  Millions$ 8.862  Millions
Ginkgo Bioworks Holdings Inc   0.14 $ 325.953  Millions$ 2,279.806  Millions
Eiger Biopharmaceuticals Inc   0.14 $ 15.481  Millions$ 108.867  Millions
Sab Biotherapeutics Inc   0.14 $ 6.417  Millions$ 45.382  Millions
Sutro Biopharma Inc   0.14 $ 56.865  Millions$ 407.640  Millions
Werewolf Therapeutics Inc   0.14 $ 24.798  Millions$ 178.243  Millions
Liquidia Corporation  0.14 $ 17.804  Millions$ 128.071  Millions
Xencor Inc  0.14 $ 113.394  Millions$ 815.767  Millions
Nektar Therapeutics  0.14 $ 87.741  Millions$ 636.907  Millions
Royalty Pharma Plc  0.14 $ 2,361.384  Millions$ 17,170.419  Millions
Plus Therapeutics Inc   0.13 $ 2.584  Millions$ 19.202  Millions
Arvinas Inc   0.13 $ 162.900  Millions$ 1,215.725  Millions
Alector Inc   0.13 $ 102.055  Millions$ 770.441  Millions
Sorrento Therapeutics Inc   0.13 $ 64.270  Millions$ 501.302  Millions
Aligos Therapeutics Inc   0.13 $ 17.252  Millions$ 134.658  Millions
Aclaris Therapeutics Inc   0.13 $ 31.168  Millions$ 246.896  Millions
Chimerix Inc   0.13 $ 33.678  Millions$ 268.210  Millions
Sintx Technologies Inc   0.12 $ 2.238  Millions$ 18.021  Millions
Mersana Therapeutics inc   0.12 $ 38.717  Millions$ 314.096  Millions
Regenxbio Inc   0.12 $ 96.972  Millions$ 786.837  Millions
Whitehawk Therapeutics Inc   0.12 $ 21.541  Millions$ 175.056  Millions
Rhythm Pharmaceuticals Inc   0.12 $ 43.764  Millions$ 356.929  Millions
Petros Pharmaceuticals inc   0.12 $ 3.852  Millions$ 32.354  Millions
Marinus Pharmaceuticals Inc   0.12 $ 25.963  Millions$ 218.094  Millions
Titan Pharmaceuticals Inc   0.12 $ 0.396  Millions$ 3.329  Millions
Delcath Systems Inc   0.12 $ 2.636  Millions$ 22.434  Millions
Astrazeneca Plc  0.12 $ 11,416.000  Millions$ 97,657.000  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.